Literature DB >> 1126047

Relation of steatosis to cirrhosis.

H Thaler.   

Abstract

Steatosis of the liver is a harmless symptom of disturbed lipid metabolism but not a disease. The cause of the steatosis, and not the fat accumulation by itself, produces cirrhosis. There is no evidence so far in man that cirrhosis may be caused by nutritional deficiencies alone. Even cirrhosis after small bowel bypass procedures seems to be result from metabolic rather than nutritional disturbances.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1126047

Source DB:  PubMed          Journal:  Clin Gastroenterol        ISSN: 0300-5089


  11 in total

1.  Prevalence of liver disease in cystic fibrosis.

Authors:  R Scott-Jupp; M Lama; M S Tanner
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

Review 2.  Histopathology of nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt; Dina G Tiniakos
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

Review 3.  Developmental programming of pediatric nonalcoholic fatty liver disease: redefining the"first hit".

Authors:  Michael S Stewart; Margaret J R Heerwagen; Jacob E Friedman
Journal:  Clin Obstet Gynecol       Date:  2013-09       Impact factor: 2.190

Review 4.  Transitions of histopathologic criteria for diagnosis of nonalcoholic fatty liver disease during the last three decades.

Authors:  Yoshihiro Ikura
Journal:  World J Hepatol       Date:  2014-12-27

5.  Non-invasive means of measuring hepatic fat content.

Authors:  Sanjeev-R Mehta; E-Louise Thomas; Jimmy-D Bell; Desmond-G Johnston; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

6.  Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis.

Authors:  A Nonomura; Y Mizukami; M Unoura; K Kobayashi; Y Takeda; R Takeda
Journal:  Gastroenterol Jpn       Date:  1992-08

Review 7.  Role of liver biopsy in nonalcoholic fatty liver disease.

Authors:  I L Ke Nalbantoglu; Elizabeth M Brunt
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

8.  Drug metabolism in diabetic subjects with fatty livers.

Authors:  H I Pirttiaho; P I Salmela; E A Sotaniemi; R O Pelkonen; U Pitkänen; P V Luoma
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

9.  Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?

Authors:  C D J Evans; K A Oien; R N M MacSween; P R Mills
Journal:  J Clin Pathol       Date:  2002-09       Impact factor: 3.411

Review 10.  From the origin of NASH to the future of metabolic fatty liver disease.

Authors:  Andreas Geier; Dina Tiniakos; Helmut Denk; Michael Trauner
Journal:  Gut       Date:  2021-02-25       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.